MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

INTRODUCTION: Breast cancer is a heterogeneous disease encompassing a number of phenotypically diverse tumours. Expression levels of the oestrogen, progesterone and HER2/neu receptors which characterize clinically distinct breast tumours have been shown to change during disease progression and in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowery, Aoife J, Miller, Nicola, Devaney, Amanda, McNeill, Roisin E, Davoren, Pamela A, Lemetre, Christophe, Benes, Vladimir, Schmidt, Sabine, Blake, Jonathon, Ball, Graham, Kerin, Michael J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716495/
https://www.ncbi.nlm.nih.gov/pubmed/19432961
http://dx.doi.org/10.1186/bcr2257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716495/
https://www.ncbi.nlm.nih.gov/pubmed/19432961
http://dx.doi.org/10.1186/bcr2257

Ejemplares similares